baber/WOPTO huggingface dataset:
Patent DK-573984-D0 (DK)
Inventor: BABLET MAURICE
IPC: B65D19/08
Filed: 1984-12-04
Abstract: 1. A stackable pallet-crate formed of four upright posts (1) rigidly interconnected by a floor member (2), each post (1) carrying sliding channels (5, 6) into which are inserted removable lateral panels (7, 12) ; the internal faces (6) and the external faces (5) of the sliding channels being of uneven heights, the external face (5) extending over at least the full usable height of the crate, this height being equal to an integer multiple of the width of the pannel (7, 12) to which is added a substantial fraction (x) of this width, characterized in that the height of the internal face (6) equals the integer multiple being immediately smaller than said height to which is added a fraction (y) of said height being approximately equal to or smaller than the previous fraction, so that the difference of heights (x + z) between the internal face (6) and the external face (5) will be approximately equal to or larger than one panel width (7, 12).
Patent NO-865228-D0 (NO)
Inventor: BAYLES RICHARD WILLIAM
IPC: C07D309/30
Filed: 1986-12-22
Abstract: Compounds of formula I: <CHEM>  wherein:  R1 is hydrogen or alkyl; R2 is alkyl optionally substituted by one or more alkoxy groups or halogen atoms; X is a group of formula -0R3 wherein R3 is alkyl, cycloalkyl, or arylalkyl; or X is a group of formula -NHCVR4 wherein V is oxygen or sulphur, R4 is hydrogen, alkyl, cycloalkyl (which alkyl and cycloalkyl groups may be substituted), alkenyl, aryl, arylalkyl, amino, mono- or di-alkylamino or a group of the formula -OR5 wherein R5 is optionally substituted alkyl, aryl or arylalkyl; or X is a group of formula -NHSO2R4a wherein R4a is alkyl, aryl or a group of formula -CH2COR4b wherein R4b is alkyl or aryl; Y is optionally substituted alkoxy, cycloalkoxy, arylalkoxy or a group of formula -NR6R7 wherein R6 is hydrogen or alkyl and R7 is alkyl, cycloalkyl (which alkyl and cycloalkyl groups may be substituted), aryl or arylalkyl or R7 is a group of formula -COOR8 wherein R8 is alkyl are useful intermediates in the synthesis of beta-lactam antibiotics.
Patent NO-870214-D0 (NO)
Inventor: CROUZET PIERRE
IPC: C08F4/64
Filed: 1987-01-19
Abstract: The invention relates to processes and apparatus for the elutriation of particles of a Ziegler-Natta type alpha-olefin polymerisation catalyst, based on transition metal compound(s) and preferably also comprising magnesium compounds, by means of an elutriation liquid which is a non-polar liquid, for example a hydrocarbon chemically inert in relation to the catalyst. A preferred process comprises the following stages:- preparation of a homogeneous suspension of the catalyst in the elutriation liquid. and- elutriation of the catalyst by means of the suspension and the elutriation liquid in one or two elutriation columns (F1),(F2), separating the large and fine catalyst particles respectively.The apparatus comprises a tank (M2) for the preparation of the catalyst suspension and the elutriation column or columns (F1)(F2).The invention also relates to elutriation of Ziegler-Natta catalyst particles using a non-polar elutriation liquid and wherein a special polar aprotic additive is employed, for example an organo-metallic compound.
Patent NO-874855-D0 (NO)
Inventor: WIDLER LEO
IPC: C07F9/547
Filed: 1987-11-20
Abstract: Heteroarylaminomethanediphosphonic acids of the formula <IMAGE> in which R1 represents an optionally benzo- or cyclohexeno-fused 5-membered heteroaryl radical having 2 to 4 N atoms or 1 or 2 N atoms and 1 O or S atom as hetero atom(s) and which is unsubstituted or substituted by lower alkyl, phenyl which is unsubstituted or substituted by lower alkyl, lower alkoxy and/or halogen, lower alkoxy, hydroxyl, di-lower alkylamino, lower alkylthio and/or halogen and R2 denotes hydrogen or lower alkyl, and their salts have an action regulating the metabolism of calcium and can be used as pharmaceutical active compounds for the treatment of diseases which can be traced back to disorders thereof. They are prepared, for example, by converting the group(s) X into free phosphono in a compound of the formula <IMAGE> in which X1 denotes a functionally modified phosphono group X and X2 denotes phosphono or likewise a functionally modified phosphono group X.
Patent NO-885421-D0 (NO)
Inventor: OLIVER RAYMOND
IPC: B01J2/18
Filed: 1988-12-06
Abstract: Liquid jets are broken up in a controlled manner by the use of an asymmetric disturbance, so as to provide substantially spherical droplets having a desired size distribution. This method is of particular utility in the manufacture of fertilizers and sodium hydroxide.
Patent NO-891352-D0 (NO)
Inventor: HEIKONEN MATTI
IPC: A23K3/03
Filed: 1989-03-30
Abstract: The invention relates to a process and a preservative for the preservation of animal feed. According to the process, acid-containing substance is added to fresh, newly harvested fodder in an amount sufficient to increase the acidity of the fodder immediately to below 4.5 at the most, preferably to below 4 in accordance with the principle of the AIV System. Spent liquor from acid pulping, optionally concentrated to desired concentration, is used as acid-containing substance. According to the invention, the liquor used consists of the spent liquor from a pulping process, wherein formic acid and/or a mixture of formic acid and hydrogen peroxide has been used for defibering the cellulosic raw material. Such a solution contains before concentration about 30 to 50 weight per cent lignin, about 5 to 20 weight per cent poly-saccharides, about 10 to 20 weight per cent mono- and oligosaccharides and about 30 to 50 weight per cent monosaccharides and lignin fragments calculated on basis of the dry matter. The pH of the ensilage feed can easily be adjusted to its most preferable value (3.5 to 4.0), while securing a sufficient amount of sugars and, thus, accurate fermentation by means of the sugars in the spent liquors.
Patent NO-902013-D0 (NO)
Inventor: SYGNATOR HENRY A
IPC: B21G3/00
Filed: 1990-05-07
Abstract: A wire nail (10) having a shank (12), a head (14) formed on one end of the shank, and a point (16) formed on the other end. The point has a penetrating portion, a wedging portion, and a transitional portion. The wedging portion defines four straight edges, each being inclined at an acute angle relative to an axis defined by the shank. The transitional portion defines four straight edges, each meeting a different one of said edges defined by the wedging portion, and each being inclined at a lesser angle relative to the same axis. The wedging portion has a plurality of convex surfaces, each conforming generally to a section of a circular cylinder. The transitional portion has a plurality of convex surfaces, each conforming generally to a section of a circular cylinder. A cutting tip is formed as a thin rib extended across the penetrating portion. A pair of thin cutting ribs extended from the cutting tip are formed along the wedging and transitional portions.
Patent NO-912793-D0 (NO)
Inventor: MOHN FRANK
IPC: H01R13/523
Filed: 1991-07-17
Abstract: PCT No. PCT/GB90/00082 Sec. 371 Date Sep. 13, 1991 Sec. 102(e) Date Sep. 13, 1991 PCT Filed Jan. 18, 1990 PCT Pub. No. WO90/08406 PCT Pub. Date Jul. 26, 1990.Apparatus for coupling a subsea module to an umbilical termination head from a subsea installation which comprises a receiver (14) mounted on the module, a receiver (15) mounted on the umbilical, and a conductive insert coupling (CIC) (13). The receivers (13, 14) each have electrical terminal sets (24, 25). The CIC (13) has a pair of spaced electrical terminal sets (22, 23) in which respective terminals in each set are electrically connected by concentric conductive tubes. The receivers (14, 15) are arranged to receive the CIC (13) so that when it is in position in the receivers (14, 15), each of the CIC terminal sets (22, 23) contacts one of the receiver terminal sets (24, 25) thereby forming an electrical connection between the two receiver terminal sets (24, 25).
Patent NO-914805-D0 (NO)
Inventor: LANKINEN TAPIO
IPC: A61M15/00
Filed: 1991-12-06
Abstract: A device for a more effective pulverization of particles and/or agglomerates of a powdered inhalation medicament, comprising a chamber (2) intended for medicament and substantially closed at one end thereof, said chamber being provided with at least one air inlet port and a powdered medicament outlet port. The chamber (2) substantially closed at one end said, chamber being rotationally symmetrical in shape or its cross-section perpendicular to the centre axis thereof being substantially circular in shape and without substantial flow obstacles. The inlet and outlet ports are spaced from each other in the direction of the centre axis of chamber (2). Said inlet port (1) being designed to direct the air inflow into the vortex chamber substantially parallel to the tangent of said chamber.
Patent NO-920298-D0 (NO)
Inventor: VENKATESAN ARANAPAKAM M
IPC: A61P9/12
Filed: 1992-01-22
Abstract: Novel quinazolinone compounds of the formula: <CHEM> wherein R<5>, R<6>, R<7>, R<8>, R and X are defined in the specification, which have angiotensin II (AII) antagonizing activity, intermediates useful in the preparation of the compounds, methods of producing and using the compounds to alleviate angiotensin induced hypertension and treat congestive heart failure in mammals.
Patent NO-924792-D0 (NO)
Inventor: FLORES JOSUE GARZA
IPC: A61K9/16
Filed: 1992-12-11
Abstract: New non-porous solid microspheres have a dia. of 1-300 microns and consist of at least one injectable drug. More Specifically the dia. is 5-100 microns. The microspheres have a m.pt. above 60 deg. C and may contain additives. The microspheres are formulated as suspensions in aq. media (esp. saline) or oils in which they are insoluble. Contraceptive formulations contain progesterone microspheres and 17beta-oestradiol microspheres. Post partum (sic) contraceptive formulations, and formulations for prevention of osteoporosis in menopausal women, contain progesterone microspheres. Analgesic formulations contain naproxen or indomethacin. The microspheres are produced by melting the drug in an inert gas atmos., spraying the melt under inert gas pressure, cooling the spray to solidify the droplets, and screening the resulting microspheres.
Patent NO-930465-D0 (NO)
Inventor: HASEGAWA MASAKATSU
IPC: C07D239/38
Filed: 1993-02-10
Abstract: An oxidized composite comprising a water-soluble carboxypolysaccharide and ultrafine magnetic iron oxide particles. It has an extremely reduces toxicity and an excellent stability, exhibits scarcely any or no hypotensive activity even if directly administered into the blood vessel of an animal, is reduced in the activity of platelet agglutination, and is useful in the medical field as, for example, a contrast medium for MRI and a pyrogenic agent for thermotherapy.
Patent NO-934431-D0 (NO)
Inventor: RIJSEWIJK FRANCISCUS ANTONIUS
IPC: C12N7/01
Filed: 1993-12-06
Abstract: Deletion mutant of bovine herpesvirus type 1 which has a deletion in the glycoprotein gE-gene. The mutant may further have a deletion in the thymidine kinase gene and/or the glycoprotein gI-gene, or have an insertion of a heterologous gene. Recombinant nucleic acid which comprises the gE-gene or a part thereof. Glycoprotein gE, peptides based thereon and complexes of the glycoproteins gE and gI, and antibodies against them. Vaccines and diagnostic kits comprising any one of these materials.
Patent NO-950712-D0 (NO)
Inventor: LAVIELLE GILBERT
IPC: C07D413/14
Filed: 1995-02-24
Abstract: Benzodioxane derivs. of formula (I), their enantiomers, diastereomers and epimers, and their acid or base addn. salts, are new. X = O or -CH2-; n = 1-3; R1 = H, aminocarbonyl or hydroxymethyl: R2 = N(R3)R4; R3 = H or 1-6C alkyl; R4 = 1-4C alkyl (opt. substd. by phenyl (opt. substd. by one or more halo, 1-4C alkyl, 1-4C alkoxy, trihalomethyl or hydroxy) provided that R1 is not H), or 1-4C alkyl (substd. by benzoylamino (opt. substd. on the phenyl nucleus)), or benzoyl (opt. substd. are phenyl above), or R3R4N to which they are bonded form a gp. (i); m = 1-3; R5 = benzoyl or benzoylmethyl (both opt. substd. by phenyl), or 1H-imidazol-3-yl methyl or 1,2-benzisoxazol-3-yl methyl(both opt. substd. on phenyl by a halogen atom), or 2-oxo-(3H)-benzimidazol-1-yl.
Patent NO-954221-D0 (NO)
Inventor: STAVDAHL OEYVIND
IPC: A61F4/00
Filed: 1995-10-23
Abstract: Described is a method for controlling prostheses and other assistive devices using tissue whose state is influenced by the central nervous system of a user. The state of the tissue is sensed, and information from this sensing is fed into a unit (9, 10) that estimates the motor intention of the user and controls the prosthesis according to this estimate. The method comprises transmission of ultrasound signals into the tissue by use of an ultrasound transducer (6) and then reception of the ultrasound signals modulated by the tissue by use of an ultrasound transducer (7). Based on these received ultrasound signals, the motor intention of the user is estimated, and based on this mentioned estimate a number of prosthesis states are controlled.
Patent NO-962845-D0 (NO)
Inventor: PERSSON MICHAEL
IPC: D21H21/10
Filed: 1996-07-05
Abstract: The invention relates to a process for the production of paper from a suspension of cellulose containing fibres, and optional fillers, wherein a low molecular weight cationic organic polymer, a high molecular weight cationic or amphoteric polymer and anionic inorganic particles are added to the suspension and the suspension is formed and drained on a wire, wherein the low molecular weight polymer has a molecular weight below 700,000, the high molecular weight polymer has a molecular weight above 1,000,000 and said polymers are simultaneously added to the suspension. The invention further relates to a polymer mixture in the form of an aqueous dispersion comprising at least one high molecular weight cationic or amphoteric acrylamide-based polymer having a molecular weight above 1,000,000, at least one low molecular weight cationic organic polymer having a molecular weight below 700,000 and at least one water-soluble inorganic salt, wherein the weight ratio of said high molecular weight polymer to said low molecular weight polymer is within the range of from 9:1 to 1:2.
Patent NO-964233-D0 (NO)
Inventor: DUCHACZEK HUBERT
IPC: B01D53/96
Filed: 1996-10-04
Abstract: The invention concerns a process for purifying waste furnace gases and for using the resultant filter residue. Alkaline aggregates, containing sodium or potassium as the cation, are added to the waste furnace gas. In a subsequent stage, dusts and droplets are filtered out of the waste furnace gas. The resultant filter residue is added to the cover salt (7) necessary when melting secondary aluminium.
Patent NO-972080-D0 (NO)
Inventor: WAGNER JOACHIM
IPC: F42B39/00
Filed: 1997-05-06
Abstract: The transporting container (10) has a tubular shell (16) to which the container bottom (20) is fixed, and a removable cover. The tubular shell is made with longitudinal intended break points (38), distributed uniformly round the circumference and running in the axial direction of the shell. The tube shell has external stacking bars (46). These extend over the entire length of the shell, and are arranged in the circumferential direction of the intended break points and distributed uniformly round the circumference. The longitudinal break points may be built on the inner surface (36) of the tubular shell. The stacking bars may be built from angled profiles provided with ventilation holes (52).
Patent NO-975023-D0 (NO)
Inventor: BOLIN DAVID ROBERT
IPC: A61K38/08
Filed: 1997-10-31
Abstract: The present invention relates to vasoactive peptide (VIP) analogs wherein the side chain carboxy terminus of one amino acid in the peptide chain is attached covalently to the side chain amino terminus of another amino acid in the peptide chain via the formation of an amide bond. The covalent bonding between the two amino acid residues in the peptide chain yields a ring structure. The present invention provides cyclic vasoactive peptides and pharmaceutical compositions comprising such a cyclic vasoactive peptide for the treatment of bronchotracheal constrictive disorders.
Patent NO-991215-D0 (NO)
Inventor: KIMBALL ROBERT H
IPC: H04W88/02
Filed: 1999-03-11
Abstract: A conference calling system for a wireless communications channel. The system is adapted for use with a channel having first, second and third participants communicating via first, second and third transmitters and receivers respectively. The system includes a circuit for receiving an encoded signal from at least one of the transmitters. A second circuit determines which of the participants is speaking from the received encoded signal. A third circuit is provided for re-transmitting an encoded signal received from the speaking participant to the other participants. In the illustrative implementation, the encoded signals are variable rate speech vocoded signals in which speech is vocoded at full rate, silence is vocoded at +E,fra 1/8+EE th rate and the +E,fra 1/2 +EE  and +E,fra 1/4+EE  rates are used as transitional rates. In the illustrative implementation, the speaker's signal is identified by examining the rate of the received vocoded signals. When the speaker's vocoded signal is identified, it is re-transmitted without de-vocoding to the non-speaking participants in the conference call. By re-transmitting the speaker's signal without de-vocoding, the quality of the received signal is preserved.
Patent NO-993436-D0 (NO)
Inventor: HAMMER ERLING
IPC: G01N33/28
Filed: 1999-07-12
Abstract: A method and a device for measuring interphase levels between fluids are disclosed. The method is  characterised in that  a variable magnetic field is established in one of the fluids by means of a device creating a magnetic field, whereby a counter-flowing magnetic field is established, being a function of the properties of the fluid with respect to the portion of conductive fraction in the fluid, and the conductivity of the fraction; and the properties of the mentioned fluid are registered by registering of the system's prominent impedance, alternatively a resonance frequency, and by corresponding registration in different fluid layers at various height levels, and in the existing interphase layers, and thereafter mutual comparison of mentioned properties, one or more interphase levels that are present are determined. An application of the device and method for determination of interphase layers during separation of oil, gas and water phases are also discclosed.
Patent NO-994809-D0 (NO)
Inventor: ALPERINE SERGE ALEXANDRE
IPC: C23C14/06
Filed: 1999-10-01
Abstract: A poorly conducting thermal barrier coating applied on a superalloy substrate comprises a mixture of oxides consisting of a composition based on zirconia, 3-15 weight % of an oxide, preferably yttria, that stabilizes the zirconia, 0.5-12 weight % of an additional metallic element selected from Ni, Co, Fe or a mixture of Ni and/or Co and/or Fe, or their oxides, and 0.02-0.1 weight % C. The homogeneous oxide mixture is deposited on the substrate by electron beam evaporation of a bar having a composition consisting of the above thermal barrier coating composition. The mixture can also be applied by thermal or plasma spraying, (plasma-assisted) chemical vapor deposition. A sublayer of nickel-aluminum alloy containing at least one metal selected from Cr, precious metals of crude platinum , yttrium and rare earths can be interposed between the substrate and the oxide mixture layer. Preferably the sublayer has formula MCrAlY, where M = at least one metal selected from Ni, Co and Fe. Independent claims are given for: (a) a superalloy metal piece whose surface is coated at least in part with the thermal barrier; and (b) a process for deposition of the thermal barrier on a superalloy substrate. The deposition process involves (i) mixing and sintering into the form of a bar a mixture of powders of zirconia, a zirconia-stabilizing oxide, and an element selected from Ni, Co and Fe; (ii) introducing the body to into an EB-PVD chamber previously loaded with the bar; and (iii) creating a vacuum in the chamber, preheating the substrate, and focussing an electron beam on the bar in order to vaporize the elements present in the bar so that they condense onto the substrate.   In (i), mixing of the powders is achieved by using a binder comprising a solvent that is at least partially rich in carbon, preferably a polyvinyl alcohol. A thermally crackable, carbon precursor gas selected from methane, ethane, butane, propane, an alkene or alkyne, is introduced into the deposition chamber in the immediate vicinity of the substrate to be coated.
Patent NO-995462-D0 (NO)
Inventor: HEINS SHERRY DARLENE
IPC: A01N63/50
Filed: 1999-11-08
Abstract: The present invention relates to a novel antibiotic-producing and metabolite-producing Bacillus subtilis strain that exhibits insecticidal, antifungal and antibacterial activity. The supernatant of this novel strain contains effective insecticidal, antifungal and antibacterial agents. Also included in the invention is a solvent extractable, small molecular weight (<10,000 daltons) corn rootworm-active metabolite produced in the supernatant. Also included in the invention are methods of protecting or treating plants from fungal and bacterial infections and corn rootworm infestations comprising the step of applying to the plant an effective amount of the antibiotic/metabolite-producing novel Bacillus subtilis strain, the antibiotic/metabolite produced by the novel Bacillus subtilis strain or a combination thereof, optionally further comprising another antibiotic-producing bacterial strain and/or a chemical pesticide. The invention also includes methods of preventing or treating fungal and bacterial infections using whole broth cultures or supernatants obtained from cultures of the novel Bacillus subtilis strain alone or in combination with chemical pesticides and/or other biocontrol agents. The invention also includes novel antifungal and antibacterial compounds designated agrastatins and a novel combination comprising an A-type iturin, a plipastatin, a surfactin and an agrastatin. Methods of treating or protecting plants from fungal and bacterial infections and corn rootworm infestations comprising administering the novel agrastatins and the novel combination comprising an A-type iturin, a plipastatin, a surfactin and an agrastatin are provided.
Patent GB-0002927-D0 (GB)
Title: Personal safety system
IPC: H04M3/22
Filed: 2000-02-10
Abstract: The system is based on a central computer (10) which holds details, for each of a number of users, of visits to be made and a termination time for each. These details may be logged by the user calling on a mobile phone (16) and providing the details as a mixture of voice, held in a voice recording system (12), and keyed data held in the computer (10). In the event that the user does not confirm termination of the visit before the stated time, the computer (10) initiates a call to the user's mobile phone (16) and in the absence of a satisfactory response sends an automatic call to the telephone (18) of a designated person such as the user's employer.
Patent GB-0108333-D0 (GB)
Title: Method and apparatus for providing network access for PDA devices
IPC: H04L29/06
Filed: 2001-04-03
Abstract: A method and apparatus for communicating data from a Personal Digital Assistant (PDA) device over a network is described. In a preferred embodiment, the data is received from the PDA device by a network device through a short-range wireless interface. The network device determines the format of the received data and converts it to a data packet format suitable for transmission across the network.
Patent GB-0208433-D0 (GB)
Title: Deformation of thin walled bodies
IPC: B44B5/00
Filed: 2001-02-09
Abstract: The predetermined wall zone for deformation is co-aligned with the tooling by means of co-ordinated movement of the tooling, i.e. rotation about a tooling axis, prior to engagement with the wall zone.
Patent GB-0221451-D0 (GB)
Title: Gas generator
IPC: A61M16/10
Filed: 2002-09-16
Abstract: A gas generator insulated by a vacuum-jacket vessel.